A new liquid biopsy technique, CancerSEEK, that evaluates tumor mutations and cancer-linked proteins can detect 70% of cancers in patients who have one of eight tumor types. The technique can pinpoint the location of a tumor in 68% of cases. However, its sensitivity drops off at earlier disease stages.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2t3HQoI
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου